Royalty Pharma plc

Royalty Pharma Misses on EPS, Stock Down Unknown%

Royalty Pharma reported a loss per share of $-0.21, which was below expectations. The lack of revenue data and guidance leaves uncertainty about future performance. Without a stock reaction noted, it is unclear how investors are responding to these results.